Heartflow Inc Dossier
Financial Snapshot
Revenue, profitability, returns, debt, and capital allocation
Revenue $176M+39.9% YoYTTM through 31 Dec 2025
Net Income -$116.8MTTM through 31 Dec 2025
Free Cash Flow -$59MTTM through 31 Dec 2025
Margins
| Current | |
|---|---|
| Gross Margin | 76.8% |
| Operating Margin | -36.4% |
| Net Margin | -66.4% |
Returns
-38.8%ROE
-32.5%ROA
Balance Sheet Health
Debt / Equity0.00x
Current Ratio5.20x
Net Debt-$176.8Mnet cash position
Cash & Equivalents$44.8M
Quality Metrics
FCF Margin-33.5%
Rule of 407.9
Earnings-Beat Rate50.0%
Dividend
No dividend
Segment Performance
| Segment | Revenue | YoY | Outlook |
|---|---|---|---|
| Heartflow FFRCT Analysis | $172.5M | View detailsRemains the commercial foundation of the company with durable growth. | |
| Heartflow Plaque Analysis & Other | $3.5M | View detailsNascent commercialization with accelerating adoption and expanding payer coverage (e.g., Aetna, UnitedHealthcare, Cigna). |
Filing Detail Members
This section is available to registered members. Create a free account or sign in to unlock the full breakdown.